Hydrodynamic gene delivery to the liver is a valuable experimental tool and an attractive option for nonviral gene therapy of liver disease. However, little attention has been paid to the major obstacle to clinical application: acute volume overload of the cardiovascular system. We delivered volumes of DNA solution (pGL3 plasmid) corresponding to 1, 2, 4, 6 and 8% of the body weight at 100 ml/min to the inferior vena cava (IVC) of DA strain rats. Central venous pressure (CVP), arterial pressure, pulse and electrocardiogram (ECG) were continuously recorded for subsequent analysis. Each volume produced a characteristic response, but all (including the 1% volume) caused severe falls in blood pressure and pulse within 1-2 s of the infusion, with ectopic beats and widening of the QRS complex in the ECG. The response to volumes of 4% and higher suggested that the liver acted as a volume sink, mitigating the immediate effects of volume overload. The 6 and 8% volumes caused profound and protracted falls in blood pressure and pulse, with a multitude of severe electrical abnormalities in the heart, including electromechanical dissociation. Vagal blockade with atropine, and the use of Ringer's solution to prevent electrolyte disturbances, did not ameliorate this picture.
Introduction
Hydrodynamic gene delivery involves the rapid infusion of large volumes of DNA solution into blood vessels. The phenomenon was discovered a decade ago in mice by Budker et al. 1 and has since been reviewed on many occasions. 2, 3 The attraction of the approach is the simplicity of the delivery system -the DNA plasmids are administered without any viral or nonviral vectors.
In the original study, 1 relatively large volumes of DNA solution (1 ml or B4% of body weight) were infused into the portal vein of mice at relatively low flow rates (2 ml/min). The concurrent use of hypertonic solutions (15% mannitol in 0.15 M NaCl) and outflow obstruction (by clamping the inferior vena cava (IVC) above and below the point of drainage of the hepatic veins) resulted in unexpectedly high levels of gene delivery to the liver (B1% of hepatocytes). Reducing the volume from 1 to 0.5 ml over the standard 30 s injection time (thereby also reducing the rate of delivery to 1 ml/min), resulted in a B70-fold reduction in gene delivery. Zhang et al. 4 extended these observations into rats, where it was shown that 15 ml volumes (representing 5-7.5% of body weight in 200-300 g rats) injected relatively slowly (either 5 or 15 ml/min) into the portal vein was effective, provided that there was outflow obstruction as described above.
In 1999, two groups reported that very high levels of gene delivery (B30% of hepatocytes) could be obtained in the livers of mice by the simple procedure of rapidly injecting large volumes of DNA solutions into the tail vein. 5, 6 Volumes corresponding to B10% of the body weight, given over 5 s (corresponding to 20-30 ml/min) were optimal. Flow rates of B5 ml/min gave poor gene delivery. Maruyama et al. 7 demonstrated this phenomenon in rats, where 10% of the body weight at 100 ml/min was optimal (B5% of hepatocytes), with much lower levels of gene delivery when the rate was reduced to 80 ml/min.
The mechanisms whereby this approach gives such high levels of gene delivery to the liver (with several 100-fold less gene delivery to other organs) remain uncertain. However, raised central venous pressure (CVP) with retrograde flow of the DNA solution into the liver via the hepatic veins, because of the low-pressure portal circulation, must play a critical role. In their original study, Zhang et al. 5 noted that the livers of mice swelled during hydrodynamic gene delivery via the tail vein. More recently, Crespo et al. 8 directly observed retrograde flow in the hepatic sinusoids. The presence of physical gaps B150 nm in diameter (fenestrae) in the endothelial cells of liver sinusoids and the absence of a basement membrane 9 are probably also important factors. Actual entry of DNA into the hepatocyte is probably mediated by the force of the perfusion, with expansion of the liver and stretching of the hepatic plate producing momentary breaks in the plasma membrane of hepatocytes. 10 As rodents survive the hydrodynamic procedure so well, little attention has been paid to the assessment of cardiovascular toxicity. Inoue et al. 11 noted that volumes corresponding to 6.25% of the body weight in rats caused a drop in blood pressure to less than 60 mm Hg, with a drop in pulse, but no further details were provided. In mice, Zhang et al. 10 noted that 10% volumes caused a drop in pulse (from B500 to B200 beats/min) and cardiac irregularities on the electrocardiogram (ECG) for approximately 1 min, but without further details.
Volume overload as a consequence of fluid absorption from body surfaces, for example during endoscopic surgery, is occasionally reported. 12 However, acute volume overload that occurs during hydrodynamic gene delivery is not seen in clinical practice and there is no clinical or experimental literature on the subject. An evaluation of the potential cardiovascular toxicity is therefore important for clinical application of modified forms of hydrodynamic gene delivery. We have performed a graded dose-response curve of different volumes at a constant flow rate for hydrodynamic gene delivery to the liver in the DA rat strain, and have simultaneously recorded for each volume the arterial blood pressure, pulse, CVP and ECG, as well as video recording of the effect of the infusion on the liver.
Results
Baseline gene delivery studies in the DA rat strain Volumes corresponding to 8, 6, 4, 2 and 1% of the body weight at a constant flow rate of 100 ml/min were evaluated. Groups of five or six rats were used, and all six lobes of each liver were individually assessed. For each rat, the mean RLU/mg of the six lobes was determined. The detailed results of the first three consecutive rats in each group are given in Figure 1 , while the values for all rats in a group are used in the following calculations. The 8% volume consistently gave high levels of gene delivery throughout the whole liver (mean7s.d. of six rats was 5.671.9 Â 10 6 RLU/mg). Reducing the volume to 6% resulted in a relatively modest B4-fold fall in gene delivery (mean7s.d. of six rats was 1.370.7 Â 10 6 RLU/mg). However, a further reduction in volume to 4% gave a B100-fold reduction in comparison with 8%. The 2 and 1% volumes gave a 4100 000-fold reduction in comparison with 8%. Each step in reduction of volume from 8 to 6 to 4% and to 2% resulted in statistically significant reductions in gene delivery (Po0.01 for all comparisons).
Gene delivery in the spleen was at least several 100-fold (often B1000-fold) lower than the liver, but followed a similar pattern.
Swelling of the liver
The swelling of the liver during and shortly after the hydrodynamic infusion is a dramatic phenomenon, which we illustrate in the accompanying video (Supplementary information movie file), mainly to support the concept of the liver acting as a volume sink. The 8% volume at 100 ml/min is shown. For volumes of 4% and higher, the liver visibly begins to swell approximately 2 s after the start of the infusion. Deflation begins immediately after the infusion stops, but is more gradual. No other abdominal organ (spleen, kidneys, intestine) shows any sign of swelling.
Cardiovascular effects of hydrodynamic gene delivery
Three rats were analysed in detail for each volume. The responses within each volume were very similar, and a typical rat from each volume is shown in detail. The peak IVC pressures for all 15 rats are given in Table 1 .
Volume as a percentage of body weight delivered at a constant 100ml /min RLU per mg protein Cardiac function during hydrodynamic gene delivery GJ Sawyer et al 1% volume. With this volume, small by hydrodynamic standards (but equivalent to a rapid infusion of 700 ml in a human), the major change is a marked but transient fall in arterial blood pressure and pulse, with substantial widening of the QRS complex on the ECG. In the rat shown (Figure 2a ), the arterial pressure (systolic/diastolic) at baseline was 103/63 mm Hg. This fell to 76/44 at 3 s after the start of the infusion, and recovered to 104/70 at 8 s. The pulse followed the arterial pressure closely. It dropped from a baseline of 353 beats/min to a trough value of 280 at around 3 s, and recovered to 369 by 9.5 s.
The IVC pressure rose from a baseline of 4.5 mm Hg to a peak of 12.4 at 2.3 s after the start of the infusion. Thereafter, it fell gradually, being 5.4 at 2 min. The trough arterial pressure and trough pulse values occurred just after the peak IVC pressure.
The major change on the ECG was a marked widening of the QRS complexes, which indicates a slowing of the spread of depolarization through the cardiac muscle. A possible cause is right ventricular dilatation and it begins abruptly at 1.5 s after the start of the infusion. From a resting value of 60 ms, the complexes widened to 87 ms at 3 s after the start of the infusion (corresponding to the trough value of the pulse) and then returned to 67 ms at 10 s after the start of the infusion. This will be illustrated The volume of DNA at 50 mg/ml in 0.15 M NaCl is given as a percentage of body weight, and was administered at 100 ml/min into the IVC. The baseline IVC pressure, just before the infusion, was o2 mm Hg in all rats except rat 1 (1%), rat 2 (2%), rat 1 (4%) and rat 1 (6%), where the baseline pressures were 4.5, 5.6, 3.4 and 3.7 mm Hg, respectively. Cardiac function during hydrodynamic gene delivery GJ Sawyer et al in detail for the 2% dose. The heart remained in normal sinus rhythm, apart from two ectopic beats during the infusion.
2% volume. The 2% volume (as compared with 1%) gave a more pronounced fall in arterial pressure and pulse. In two of the three rats, these falls were sustained for several minutes. There were also more ectopic beats during the period of the infusion, and widening of the QRS complex on the ECG was greater and more sustained.
In the rat shown (Figure 2b ), the arterial pressure dropped from a baseline of 105/69 mm Hg to a trough of 74/35 at 7.6 s, and then rose to a plateau of 89/54 at 11.7 s. The pulse again closely followed the arterial pressure, dropping from a baseline value of 346 beats/min to 230 at 3.5 s, and rising to 298 at 8.5 s. These values gradually returned towards normal. At 2 min after the start of the infusion, the arterial pressure was 91/51 and the pulse 327.
The IVC pressure rose from a baseline of 5.6 mm Hg to a peak of 20.0 at 3.2 s. There was an initial relatively rapid fall, and then a steady fall to 6.8 at 1 min and 6.3 at 2 min.
As in the 1% dose, the major ECG change was the almost immediate onset of QRS widening, associated with several ectopic beats and a marked slowing of the cardiac rate, as illustrated in Figure 2c . Widening of the QRS complexes is evident by the seventh beat, and the tenth beat is an ectopic. From a resting value of 62 ms, the QRS complexes widened to 109 ms at 3 s, and then returned towards normal, being 100, 79, 70 and 66 ms at 7, 10, 20 and 30 s after the start of the infusion. The increased amplitude of the ECG after the infusion (that is increased voltage change above and below the baseline, best seen in Figure 2b ) is probably caused by a change in the position of the heart in the chest and cannot be interpreted in functional terms. The overall picture was one of sinus bradycardia with QRS widening, associated with several ectopic beats. 4% volume. Although the 4% volume is poor for hydrodynamic gene delivery, the cardiovascular response is severe and quite distinct from the preceding lower volumes. Of particular interest is the two-step fall in the arterial pressure and pulse (Figure 3a) , which was seen in all DA rats that were given 4% or higher volumes. Recovery began around 30-40 s after the start of the infusion, but neither diastolic pressure nor pulse had returned to normal by the end of the 5-minute-observation period. Widening of the QRS complex on the ECG was more marked and more sustained than with the lower volumes, ectopic beats were very frequent, and electrical conduction defects (a dominant characteristic of the 6 and 8% volumes) were occasionally seen in this group.
In the rat shown (Figure 3a) , baseline arterial pressure was 108/59 mm Hg. This dropped to a plateau of 70/34 at 6 s, and then rose to 85/41 at 12.5 s. Over the next 20 s, there was a second steady fall to 40/17. The arterial pressure then rose slowly towards normal over several minutes. At one, 2, 3, 4 and 5 min after the start of the infusion, arterial pressure was 48/15, 81/22, 96/32, 103/36 and 107/41, respectively. The pulse followed the arterial pressure, and fell sharply from a baseline of 344 beats/min to 131 at 6.1 s. This was followed by a steep then a gradual rise to 290 at 12.9 s. It then fell gradually to 154 over the next 19 s before beginning a slow rise. The pulse rates at 1, 2, 3, 4 and 5 min after the infusion were 202, 220, 267, 287 and 296, respectively.
It is interesting to note that the second fall in arterial pressure began 7-8 s after the cessation of the infusion, which corresponded to the peak IVC pressure.
The IVC pressure rose from 0.7 mm Hg to a peak of 51.1 at 5 s. There was a relatively steep fall to 25.6 at 8.8 s, and then a gradual fall to 9.5 at 1 min and 0.2 at 5 min.
The ECG around the time of the infusion was similar but with more extreme changes than the lower volumes (Figure 3b) . Widening of the QRS complex is obvious on the fifth beat, and the first ectopic occurs on the sixth beat. There are then numerous ectopic beats, including what appear to be junctional beats at B4.5 and B5.7 s. From a pre-infusion baseline of 63 ms, the QRS complex more than doubled to 149 ms at 7 s and lengthened further to 164 ms at 10 s. Thereafter, it fell to 93 ms at 30 s, and remained at 490 ms till the end of the 5-minute-observation period, when it was 93 ms ( Figure  3c ). In two of the three rats in this group, the second fall in blood pressure and pulse was not associated with any additional ECG changes, but in one it coincided with a 7 s run of 2:1 heart block. The ECG picture beyond 1 min was mainly one of sinus bradycardia, with occasional ectopic beats including runs of bigeminy rhythm and junctional beats and occasional nonconducted P waves (Figure 3d ). 6% volume. The 6% volume caused profound falls in blood pressure and pulse, and was characterized by a wide variety of sustained electrical conduction abnormalities in the heart. By the end of the 5-minute-observation period, systolic blood pressure was approaching normal and the heart was in sinus rhythm, but diastolic blood pressure and pulse remained low.
In the rat shown (Figure 4a) , there is the characteristic two-step fall in arterial pressure from a baseline of 107/ 61 to 46/18 at 30 s. The second fall in blood pressure began at B18 s, approximately 10 s after the cessation of the infusion at 7.9 s, as marked by the peak IVC pressure. This was co-incident in this rat with a marked fall in the heart rate (pulse) while the heart remained in sinus rhythm (Figure 4b) . Instead of progressive improvement in arterial pressure from this point, as seen in the 4% dose, the arterial pressure beyond 30 s was erratic, depending on changes in the heart's electrical conduction and the pulse. At 1, 2, 4 and 5 min, the pressures were 60/17, 66/16, 83/28 and 90/33, respectively. The pulse fell from a baseline of 324 beats/min to 141 at 6.5 s, and then to the very low level of 70 at 34 s. Thereafter it fluctuated, but rose gradually to 97, 108, 237 and 266 at 1, 2, 4 and 5 min, respectively.
The IVC pressure rose from a baseline of 1.0 mm Hg to 39.0 at 7.9 s, fell to 18.3 at 15 s, and thereafter fell slowly to 11.1, 8.0, 5.6, 4.6 and 3.6 at 1, 2, 3, 4 and 5 min, respectively. Figure 4c shows the wide QRS complexes at seven seconds, and the sudden onset of junctional rhythm, which was sustained for Btwo seconds. At 24 s there was complete heart block for 11 s, before a brief return to sinus rhythm. At B46 s, there was a 2:1 heart block ( Figure 4d ) which was sustained for 1 min and 37 s, with Cardiac function during hydrodynamic gene delivery GJ Sawyer et al occasional runs of a few beats of sinus rhythm. There was then B16 s of sinus rhythm with occasional nonconducted P waves, and thereafter (from 2 min and 20 s) there was a normal sinus rhythm, although at a slow rate. The other rats in this group showed a similar picture of ectopic beats, junctional rhythm and complete and partial heart block for 3 or 4 min after the start of the infusion. One rat showed prolonged 3:1 heart block, but returned to sinus rhythm at B4 min after the infusion.
8% volume. The 8% volume usually resulted in a transient respiratory arrest, which was not seen with the lower volumes. However, the rats were given puffs of 100% oxygen and all recovered. As with the 6% volume, there were dramatic and substantial drops in blood pressure and pulse, and the ECG was dominated by extended periods of various forms of electrical conduction defects. In addition rats given the 8% volume had extended periods where the pulse pressure gradient was o5 mm Hg, and there were many instances where QRS complexes were not associated with a pressure pulse (indicating electromechanical dissociation). By the end of the 5-minute-observation period the heart was in sinus rhythm, but neither blood pressure nor pulse had recovered to normal levels.
In the rat shown (Figure 5a ), the arterial pressure began to fall from a baseline of 108/81 mm Hg after 1.8 s, and reached the first plateau of 75/41 at 2.7 s. It then rose to 90/59 at 9 s, at which point (at the same time of the peak IVC pressure at 8.9 s), there was a dramatic fall to 28/22 at 30 s. The blood pressure fluctuated around this low level, with a very small pulse pressure for around 3 min (Figure 5b 
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The IVC pressure rose from a baseline of 0.8 mm Hg to a peak of 68.8 at 8.9 s. It fell to 30.5 over the next 3.3 s, and thereafter fell gradually. At half, 1, 2, 4 and 5 min, it was 21.1, 17.6, 13.6, 11.4 and 7.3, respectively.
The ECG around the time of the infusion showed the expected extreme widening of the QRS complex, and virtually every beat for the first 5-10 s was an ectopic. Thereafter, heart block was prominent, as in the 6% dose. One rat had complete heart block for 1 min and 20 s with a very slow ventricular rhythm (one beat every 2-5 s) (Figure 6a) . One rat showed a clear Wenckebach's phenomenon with the PR intervals (in ms) in successive beats being 80, 95, 120, nonconducted P, 80, 95, 120, nonconducted P, 75 and then an ectopic (Figure 6b) . Interestingly, the second of each set of three ECG complexes did not result in a pressure wave (Figure 6b ). Extended periods of electromechanical dissociation (cardiac depolarization which is not converted into an effective contraction) were seen in this group (Figure 6c) . Major abnormalities were present until 3.5-4.5; min after the infusion, but by 5 min the rats were in sinus rhythm.
The use of Ringer's solution
Electrolyte disturbances consequent on the rapid intravenous infusion of large volumes of 0.15 M NaCl, especially low potassium, might play a role in the ECG abnormalities and other cardiovascular problems seen in this study. We therefore performed infusions of the 8% volume of DNA at 50 mg/ml in Ringer's solution, at the standard rate of 100 ml/min. Three rats were evaluated, and all three showed arterial pressure, pulse and ECG changes very similar to the rats given the 8% volume in 0.15 M NaCl. Cardiac function during hydrodynamic gene delivery GJ Sawyer et al
Vagal blockade
Increased vagal tone can cause cardiac slowing and conduction defects. We therefore administered 0.6 mg/ kg of atropine sulphate 13 (AstraZeneca, London, UK) via the iliolumbar vein, 2-3 min before infusing the 8% volume of DNA at 50 mg/ml in Ringer's solution, at the standard rate of 100 ml/min. Three rats were evaluated. The injection of atropine (0.2 ml in a 200 g rat) caused slight increase in pulse (B10 beats/min) but no change in arterial pressure or ECG. All three rats showed arterial pressure, pulse and the ECG changes very similar to rats given the 8% volume in 0.15 M NaCl or Ringer's solution without vagal blockade.
Peak IVC pressures
These are given in Table 1 . There are three points to note. First, the peak pressures with the 8% volume (B60-75 mm Hg) are considerably higher than those reported for mice given 10% volumes (20-40 mm Hg). 8, 10 Second, although the highest levels of gene delivery to the liver (5.671.9 Â 10 6 RLU/mg) were associated with IVC pressures of 60-75 mm Hg (the 8% volume), pressures of B40 mm Hg (the 6% dose), nevertheless, still gave excellent levels of gene delivery (1.370.7 Â 10 6 RLU/mg). Third, attaining peak IVC pressures of B40 mm was not sufficient for high levels of gene delivery to the liver. The three rats given the 4% volume, with IVC 
Discussion
In this study, we establish that the volumes required for effective hydrodynamic gene delivery to the liver in a rat model are associated with major cardiac and circulatory disturbances. Even 1 and 2% volumes (which give negligible gene delivery) cause transient but severe falls in blood pressure and pulse, associated with ectopic beats and marked widening of the QRS complex on the ECG. Thus, the clinical application of hydrodynamic gene delivery to the liver, even with modified protocols that require relatively small volumes of DNA solution, 14, 15 will have to address these cardiovascular problems.
Volume overload during endoscopic surgery occurs gradually, but interestingly is also associated with bradycardia and hypotension. 12 Disentangling the mechanisms of cardiovascular toxicity with hydrodynamic gene delivery is likely to be difficult, as the electrical abnormalities in the heart and the hypotension are likely to interact with one another. It is likely that a reduction in pulse, together with reduced efficiency of pump function because of irregular beats, are important factors contributing to hypotension. Conversely, hypotension, by causing impaired coronary perfusion and myocardial ischaemia, might further exacerbate electrical problems.
Several additional factors might contribute to the hypotension. The sudden and extreme increase in CVP (which approaches arterial pressure with the higher volumes) is likely to lead to substantial dilatation of the right side of the heart. This might stretch myocardial fibres beyond the optimal length for contraction, and thus reduce contractile force (Starling's law). Additionally, dilatation of the right heart within the confines of the pericardial sac is likely to constrain function of the left heart (tamponade effect), and thereby reduce left ventricular output. With the highest volume, the heart also failed to respond to depolarization with an effective contraction, for reasons that are not clear.
The wide range and severity of electrical abnormalities in the heart could also have multiple causes, in addition to myocardial ischaemia. Stretching of myocardial fibres can alter the electrical properties of the myocardial cell and predispose to ectopic beats ('mechano-electrical feedback'). 16, 17 Increased vagal tone can cause cardiac slowing and conduction defects, but chemical blockade of the vagus nerve with atropine sulphate did not influence the cardiovascular picture, following acute volume overload. Similarly, electrolyte disturbances consequent on injecting large volumes of 0.15 M NaCl are unlikely to play a role, as the use of Ringer's solution did not alter the picture. Cardiac function during hydrodynamic gene delivery GJ Sawyer et al A novel proposal arising from this study is that the liver might act as a volume sink, and thereby mitigate the immediate cardiovascular stress of acute volume overload. Swelling of the liver during the infusion of 4% and higher volumes was remarkable, and probably involved several millilitres of fluid, thus removing a considerable part of the infused volume from the cardiovascular system. The two-stage fall in blood pressure and pulse could be a manifestation of this, as the second fall occurs after the end of the infusion, coincident with deflation of the liver.
The pressure reached in the venous system on rapidly injecting large volumes of fluid will vary with several factors, in particular, the compliance of the blood vessels and probably also of the liver. The rate of injection will also be critical, since the longer the period of the injection, the greater the opportunity for dispersal of the fluid. It is interesting in this regard that the IVC pressures reached in our studies with 8% volumes were approximately double those reached in mice with 10% volumes. 8, 10 We used 100 ml/min in our studies, and 26-30 ml/min was used in the mice, 8, 10 but relating rates of injection across species of such disparate size is not really possible. Inoue et al.
11 noted that the rapid injection (using a hand-held syringe) of a 6.25% volume in rats gave IVC pressures 'greater than 32 mm Hg', which is consistent with our result of 36-43 mm Hg in rats given the 6% volume at 100 ml/min.
In conclusion, the rapid intravenous injection of even relatively small volumes of fluid is associated with significant cardiovascular disturbances. The high volumes required for hydrodynamic gene delivery to the liver cause severe and prolonged falls in blood pressure and pulse, and serious electrical abnormalities in the heart. Identifying these problems is a step towards understanding the mechanisms involved, and minimizing them in future experimental studies and clinical applications.
Materials and methods

Rats
Inbred male rats of the DA strain weighing 180-220 g were used (Harlan UK, Oxon, UK). This weight range was strictly adhered to in order to avoid any unpredictable effects of body size.
DNA plasmid
The pGL3 plasmid containing the firefly luciferase gene (Promega, Madison, WI, USA) was used. All DNA came from a single, sterile, endotoxin-free batch of 600 mg, prepared by Plasmid Factory (Bielefeld, Germany). It was supplied frozen at 1 mg/ml in pure water and stored frozen at À351C.
DNA was made up to 50 mg/ml in 0.15 M NaCl (unless otherwise stated) for the perfusion and any unused DNA discarded. The stock DNA solution was maintained at 41C for a maximum of 2 weeks after thawing, as this has been shown not to affect activity. 18 In some experiments, the DNA was made up in Ringer's solution (0.147 M NaCl, 0.004 M KCl, 0.002 M CaCl 2 ) (Baxter Healthcare Ltd, Norfolk, UK) to minimize electrolyte imbalances following the infusion.
Hydrodynamic gene delivery and placement of pressure cannulae
All procedures were performed under isoflurane general anaesthesia, using a Zeiss operating microscope for operator and assistant. A Harvard programmable pump (model PHD 2000; Harvard Apparatus, Holliston, MA, USA) was used for delivery of the DNA, to ensure precision and reproducibility of delivery conditions. ECG leads were placed on both upper limbs and the left hind limb for continuous, three-lead monitoring. The abdomen was opened using a midline incision, and the right iliolumbar vein and the aorta were identified and dissected. For IVC pressure monitoring, a 26-gauge trochar and cannula (Abbot Laboratories, Queenborough, Kent, UK) was inserted into the iliolumbar vein, and the cannula advanced to a distance just short of the point of drainage into the IVC (usually midway between the right renal vein and the bifurcation of the IVC). For aortic pressure, a 26-gauge trochar and cannula was inserted into the aorta B1 cm caudal to the renal arteries, and the cannula advanced B2 cm cranially.
Delivery of the DNA solution was via a 21-gauge needle, inserted into the IVC near its point of bifurcation. The needle was advanced a few mm cranially and the pump activated. A small piece of gelatin sponge was placed over the needle hole as the needle was withdrawn, which was sufficient for haemostasis. IVC pressure, arterial pressure, pulse and ECG were monitored until these parameters returned to normal or for a maximum of 5 min. The venous pressure cannula was then withdrawn and the iliolumbar vein tied off. The point of puncture of the aorta was isolated between 4-0 braided silk ties, the arterial pressure cannula withdrawn, and one or two interrupted 10-0 nylon sutures were used to close the puncture hole. The ties were then removed from the aorta and the abdomen closed.
Pressure measurements
Each cannula was connected via 10 cm of saline-filled high-pressure manometer tubing (to avoid damping effects) of 1 mm diameter (Vygon (UK) Ltd, Gloucestershire, UK) to an electrical pressure transducer system (LogiCal single line transducer monitoring kit, Medex Medical, Strathclyde, UK). The saline-filled cannulae were placed at the level of the heart in the supine rat, and both transducers were opened to atmospheric pressure. This ensured that the same zero reference point was used for both transducers, and of particular importance, that the pressure measurements obtained were with reference to a constant zero baseline, namely the level of the heart. The pressure signal was converted to an analogue electrical signal using the Wheatstone Bridge principle. These signals were then passed through a strain gauge power supply and amplifier (FYLDE micro analog 2, Fylde Electronic Laboratories Ltd, Preston, UK) to a secondary amplifier and analog-to-digital converter for signal processing (BioPac UIM 100C and Model MP 100 ADC BioPac Systems, Linton Instrumentation, Norfolk, UK). The digital signal was transferred to a laptop computer where the pressure recordings were acquired and displayed graphically using AcqKnowledge waveform analysis software, version 3.9 (BioPac Systems, Linton Instrumentation, Norfolk, UK).
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The data acquisition software allowed for all recordings (including ECG) to be captured in real time and displayed in a simultaneous time domain. It also allowed for event markers to be placed in real time to highlight critical interventions.
ECG
ECG recordings were from a subcutaneous, three-lead needle electrode montage, using the standard Einthoven triangle configuration: right arm, left arm and left leg. The three-lead recordings were amplified using a BioPac ECG 100C amplifier and the resultant signal digitally converted using the Model MP 100 ADC. The processed ECG signal was transferred to a laptop computer and displayed graphically using AcqKnowledge waveform analysis software, version 3.9 (BioPac Systems, Linton Instrumentation, Norfolk, UK).
The QRS intervals given in the text are the means of five consecutive beats around the stated time.
Harvesting of liver for luciferase reporter gene expression
Livers were removed 1 day after gene delivery, and extracts of individual lobes were assayed for luciferase expression as previously described in detail. 14 
Statistical analyses
The Mann-Whitney nonparametric test was used, and differences were considered significant if Po0.05 in twotailed comparisons.
